Bausch & Lomb (TSX:BLCO) Other Operating Expense : C$406 Mil (TTM As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Bausch & Lomb Other Operating Expense?

Bausch & Lomb's Other Operating Expense for the three months ended in Sep. 2024 was C$98 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2024 was C$406 Mil.

Bausch & Lomb's quarterly Other Operating Expense increased from Mar. 2024 (C$100 Mil) to Jun. 2024 (C$101 Mil) but then declined from Jun. 2024 (C$101 Mil) to Sep. 2024 (C$98 Mil).

Bausch & Lomb's annual Other Operating Expense declined from Dec. 2021 (C$374 Mil) to Dec. 2022 (C$331 Mil) and declined from Dec. 2022 (C$331 Mil) to Dec. 2023 (C$322 Mil).

Bausch & Lomb Other Operating Expense Historical Data

The historical data trend for Bausch & Lomb's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch & Lomb Other Operating Expense Chart

Bausch & Lomb Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

458.28

413.73

373.76

331.47

321.98

Bausch & Lomb Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Other Operating Expense	Get a 7-Day Free Trial														63.60	107.33	100.17	101.42	97.53

Bausch & Lomb Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$406 Mil.

Bausch & Lomb Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Bausch & Lomb's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Bausch & Lomb Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bausch & Lomb Corp (TSX:BLCO) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

BLCO:USA S2L:Germany

Address

520 Applewood Crescent, Vaughan, ON, CAN, L4K 4B4

Website

https://www.bausch.com

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Executives